News und Analysen
Kuros Biosciences awarded 2022 Spine Technology Award for MagnetOs Flex Matrix by Orthopedics This Week
Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022
Pfizer Inc. (NYSE: PFE) will share data across its expansive infectious disease portfolio, including company-sponsored and collaborative research studies, spanning both licensed and investigational
Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
Charles River Laboratories International, Inc. (NYSE: CRL) and Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases
BD und BIOCORP unterzeichnen Vertrag, um Konnektivität und Rückverfolgbarkeit für selbst verabreichte Injektionspräparate zu schaffen
Regulatorische Nachrichten:
BD (Becton, Dickinson and Company) (NYSE: BDX), ein Weltmarktführer in der Medizintechnik, und Biocorp (Paris:ALCOR), ein in Frankreich ansässiger Hersteller von
BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
Regulatory News:
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biocorp (Paris:ALCOR), a medical device and delivery systems manufacturer based
Chemed To Report Third-Quarter 2022 Earnings October 31, Related Conference Call To Be Held On November 1
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2022, on Monday, October 31, 2022, following the close of trading on
TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen
Toronto Innovation Acceleration Partners (“TIAP”) and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the two companies have expanded
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced an oral presentation at the 35th Annual European Association of Nuclear Medicine Congress (EANM) detailing updated Phase 1 data from the Clovis
Pharnext Reports First Half 2022 Financial Results
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer
Premier, Inc.'s Subsidiary Contigo Health, LLC, Completes Asset Transaction for National Provider Contracts and Licenses to Cost Containment Technology
Premier, Inc. (NASDAQ: PINC) subsidiary Contigo Health, LLC, a provider of comprehensive services that optimize employee health benefits, today closed its transaction to acquire key assets from
Poxel Announces Upcoming Presentation at the H.C. Wainwright 6th Annual NASH Investor Virtual Conference
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
EQS-News: Burcon NutraScience Corp.: Burcon Announces Annual General Meeting Date
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating the safety, tolerability, and immunogenicity of the
EQS-News: Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2022
QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022
QuidelOrtho Corporation (NASDAQ: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a 10-µg booster dose of their
Simulations Plus Releases GastroPlus® Version 9.8.3
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of version 9.8.3 of its
Agilent Opens Center of Excellence for Dissolution Products
Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the
Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs
Humana Inc. (NYSE: HUM) and USAA Life Insurance Company (USAA Life) announced a new Medicare Advantage plan designed with veterans in mind to provide a robust coverage option that complements
Spatial Imaging of 1,000 RNAs and 100 Proteins Using the CosMx Spatial Molecular Imager Published in Nature Biotechnology
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of its first paper describing the